Patents by Inventor Jonathan Drachman

Jonathan Drachman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20240076402
    Abstract: Methods for using anti-LIV1 antibodies, including drug conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: March 7, 2023
    Publication date: March 7, 2024
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Maria Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE
  • COMBINATION THERAPY USING AN IL-2 RECEPTOR AGONIST AND AN IMMUNE CHECKPOINT INHIBITOR
    Publication number: 20230331858
    Abstract: The present disclosure is directed to, inter alia, methods for modulating an immune response in a subject in need thereof using an IL-2 receptor agonist in combination with an immune checkpoint inhibitor.
    Type: Application
    Filed: November 9, 2020
    Publication date: October 19, 2023
    Inventors: Carl WALKEY, Jonathan DRACHMAN, Umut ULGE, Daniel Adriano SILVA MANZANO
  • METHODS OF ADMINISTRATION OF IL-2 RECEPTOR AGONISTS
    Publication number: 20220370563
    Abstract: The present invention provides, inter alia, treatment regimens for administration of an IL-2 receptor agonist. The present invention is directed to, inter alia, methods for modulating an immune response in a subject in need thereof with an IL-2 receptor agonist. In some aspects, the immune response is an anti-cancer immune response.
    Type: Application
    Filed: October 22, 2020
    Publication date: November 24, 2022
    Inventors: Carl WALKEY, Jonathan DRACHMAN, Umut ULGE, Daniel Adriano SILVA MANZANO
  • HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF BREAST CANCER
    Publication number: 20200283540
    Abstract: Methods for using anti-LIV1 antibodies, including dmg conjugated anti-LIV1 antibodies, to inhibit proliferation of a LIV-1-expressing cell, as well as for the treatment of one or more diseases or disorders associated with LIV-1-expressing cells (e.g., a LIV-1-associated breast cancer), are provided.
    Type: Application
    Filed: November 30, 2018
    Publication date: September 10, 2020
    Inventors: Dana KENNEDY, Ana KOSTIC, Elizabeth CORWIN, Jonathan DRACHMAN, Peter HAUGHNEY, Baiteng ZHAO, Phillip GARFIN, Corinna PALANCA-WESSELS, Oyewale O. ABIDOYE
  • METHODS OF USING CD40 BINDING AGENTS
    Publication number: 20090304687
    Abstract: Provided are methods of using CD40 binding agents for treating a CD40-associated disease.
    Type: Application
    Filed: December 11, 2006
    Publication date: December 10, 2009
    Applicant: Seattle Genetics , Inc.
    Inventors: Jonathan Drachman, Che-leung Law, Tim Lewis
  • ANTI-CD70 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS
    Publication number: 20080025989
    Abstract: Disclosed are anti-CD70 antibodies and derivatives thereof conjugated to cytotoxic, immunosuppressive, or other therapeutic agents, as well as pharmaceutical compositions and kits comprising the antibody- and antibody derivative-drug conjugates. Also disclosed are methods, for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the disclosed pharmaceutical compositions.
    Type: Application
    Filed: April 13, 2007
    Publication date: January 31, 2008
    Applicant: Seattle Genetics, Inc.
    Inventors: Che-Leung Law, Julie McEarchern, Jonathan Drachman